Clinical value: The neglected axis in the system of research ethics

Accountability in Research

Volumn 7, Issue 2-4, 1999, Pages 255-264

  Karlawish, Jason H T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONTROL GROUP; ETHICS; HUMAN; HUMAN EXPERIMENT; MENTAL HEALTH THERAPIES; MENTAL PATIENT; METHODOLOGY; PATIENT SELECTION; PROFESSIONAL STANDARD; RESEARCH ETHICS; RESEARCH SUBJECT; RISK; RISK ASSESSMENT; SCHIZOPHRENIA; STANDARD; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; MENTAL HEALTH THERAPIES;

CLINICAL TRIALS; CONTROL GROUPS; ETHICS; ETHICS COMMITTEES; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; HUMAN EXPERIMENTATION; HUMANS; MENTALLY ILL PERSONS; NONTHERAPEUTIC HUMAN EXPERIMENTATION; PATIENT SELECTION; REFERENCE STANDARDS; RESEARCH DESIGN; RESEARCH SUBJECTS; RISK; RISK ASSESSMENT; SCHIZOPHRENIA; UNITED STATES;

EID: 0033289960     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989629908573956     Document Type: Article

References (14)

1. Anonymous. (1998). A draft report of the National Bioethics Advisory Commission. Research involving subjects with mental disorders that may affect decisionmaking capacity. Rockville, Maryland: Department of Health and Human Services; 174.
2. Anonymous. (1978). Department of Health, Education and Welfare. Protection of human subjects. Proposed regulations on research involving those institutionalized as mentally disabled. Fed. Reg., 43: 53950-6.
3. Anonymous. (1989). Cognitively impaired subjects (position paper). Ann. Intern. Med., 111: 843-8.
4. Research involving persons with mental disorders that may affect decisionmaking capacity. Rockville, MD: National Bioethics Advisory Commission; 1998.
5. Fletcher, J.C., Dommel, W. Jr. and Cowell, D.D. (1985). Consent to Research with Impaired Human Subjects. IRB: A Rev. Hum. Subj. Res., 7:1-6.
6. Melnick, V.L., Dubler, N., Weisbard, A. and Butler, R.N. (1985). Clinical Research in Senile Dementia of the Alzheimer's Type: Suggested Guidelines Addressing the Ethical and Legal Issues. Alzheimer's Dementia: Dilemmas in Clinical Research. 295-310.
7. Anonymous. (1991). Department of Health and Human Services. Common Rule, 45 CFR 46. Federal policy for the protection of human subjscts; Notices and rules. Fed. Reg., 56: 28003-32.
8. Freedman, B. (1990). Placebo-controlled trials and the logic of clinical purpose. IRB: A Rev. Hum. Subj. Res., 12:1-6.
9. High, D.M., Whitehouse, P.J., Post, S.G. and Berg, L. (1994). Guidelines for addressing Ethical and Legal issues in Alzheimer Disease Research: A position paper. Alzheimer Dis. Assoc. Disord., 8:66-74.
10. Akil, H. (1998). Letter in response to the draft report of the National Bioethics Advisory Commission, Research involving subjects with disorders that may affect decision-making capacity: American College of Neuropsychopharmacology.
11. Anonymous. (1979). The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont report: ethical principles and guidelines for the protection of human subjects of research. Fed. Reg., 44: 23192-7.
12. Freedman, B., Fuks, A. and Weijer, C. (1993). In Loco Parentis Minimal Risk as an Ethical Threshold for Research upon Children. Hastings Cent. Rep., 13-8.
13. Hirschfeld, R.M.A., Winslade, W. and Krause, T.I. (1997). Protecting subjects and fostering research: Striking the proper balance (commentary). Arch. Gen. Psychiatry 54:121-3.
14. Bell, J., Whiton, J. and Connelly, S. (1998). Final Report. Evaluation of NIH implementation of section 491 of the Public Health Service Act, mandating a program of protection for research subjects. Arlington: The Office of Extramural Research, National Institutes of Health; 86.